GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adverum Biotechnologies Inc (LTS:0HA3) » Definitions » Net Margin %

Adverum Biotechnologies (LTS:0HA3) Net Margin % : -2,713.40% (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Adverum Biotechnologies Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Adverum Biotechnologies's Net Income for the three months ended in Sep. 2024 was $-27.13 Mil. Adverum Biotechnologies's Revenue for the three months ended in Sep. 2024 was $1.00 Mil. Therefore, Adverum Biotechnologies's net margin for the quarter that ended in Sep. 2024 was -2,713.40%.

The historical rank and industry rank for Adverum Biotechnologies's Net Margin % or its related term are showing as below:

LTS:0HA3' s Net Margin % Range Over the Past 10 Years
Min: -25794.4   Med: -3847.92   Max: -1940.53
Current: -9411.1


LTS:0HA3's Net Margin % is ranked worse than
90.82% of 1013 companies
in the Biotechnology industry
Industry Median: -140.3 vs LTS:0HA3: -9411.10

Adverum Biotechnologies Net Margin % Historical Data

The historical data trend for Adverum Biotechnologies's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adverum Biotechnologies Net Margin % Chart

Adverum Biotechnologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -25,794.40 - -1,940.53 - -3,254.58

Adverum Biotechnologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -2,713.40

Competitive Comparison of Adverum Biotechnologies's Net Margin %

For the Biotechnology subindustry, Adverum Biotechnologies's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Adverum Biotechnologies's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adverum Biotechnologies's Net Margin % distribution charts can be found below:

* The bar in red indicates where Adverum Biotechnologies's Net Margin % falls into.



Adverum Biotechnologies Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Adverum Biotechnologies's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-117.165/3.6
=-3,254.58 %

Adverum Biotechnologies's Net Margin for the quarter that ended in Sep. 2024 is calculated as

Net Margin=Net Income (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-27.134/1
=-2,713.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adverum Biotechnologies  (LTS:0HA3) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Adverum Biotechnologies Net Margin % Related Terms

Thank you for viewing the detailed overview of Adverum Biotechnologies's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Adverum Biotechnologies Business Description

Traded in Other Exchanges
Address
100 Cardinal Way, Redwood CIty, CA, USA, 94063
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.

Adverum Biotechnologies Headlines

No Headlines